SHW
Sherwin-Williams Co/The
NYSE · Chemicals
$361.98
+0.94 (+0.26%)
Income Statement
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | 23.34B | 53.44B | 22.86B | 52.34B | 45.76B |
| Net Income | 2.54B | 5.82B | 2.24B | 5.13B | 5.47B |
| EPS | — | — | — | — | — |
| Profit Margin | 10.9% | 10.9% | 10.4% | 10.4% | 12.0% |
| Rev Growth | +2.1% | +2.1% | +2.1% | +2.1% | +0.7% |
Balance Sheet
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Total Debt | 31.53B | 31.53B | 31.53B | 31.53B | 6.29B |
| Total Equity | 13.34B | 13.34B | 13.34B | 13.34B | 36.13B |
| D/E Ratio | 2.36 | 2.36 | 2.36 | 2.36 | 0.17 |
Cash Flow
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| EBITDA | 3.81B | 8.71B | 3.54B | 8.11B | 10.68B |
| Free Cash Flow | — | — | — | — | 6.12B |